Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation

Mohseni, Rashin; Mahdavi Sharif, Pouya; Behfar, Maryam; Shojaei, Sahar; Shoae-Hassani, Alireza; Jafari, Leila; Khosravi, Abbas; Nikfetrat, Zeynab; Hamidieh, Amir Ali

doi:10.1038/s41598-024-70958-7

Sci Rep

2024

DOI: 10.1038/s41598-024-70958-7

|View full text |Cite

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation

Rashin Mohseni,

Pouya Mahdavi Sharif,

Maryam Behfar

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2025

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Natural killer cell-based therapies in neuroblastoma

Ghasempour,

Mohseni,

Sharif

et al. 2025

Cellular Immunology

View full text Add to dashboard Cite

Natural killer cell-based therapies in neuroblastoma

Ghasempour,

Mohseni,

Sharif

et al. 2025

Cellular Immunology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation

Cited by 1 publication

References 72 publications

Natural killer cell-based therapies in neuroblastoma

Natural killer cell-based therapies in neuroblastoma

Contact Info

Product

Resources

About